HIRAFBI Trademark

Trademark Overview


On Wednesday, March 16, 2016, a trademark application was filed for HIRAFBI with the United States Patent and Trademark Office. The USPTO has given the HIRAFBI trademark a serial number of 86942779. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 5, 2023. This trademark is owned by Glaxo Group Limited. The HIRAFBI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
hirafbi

General Information


Serial Number86942779
Word MarkHIRAFBI
Filing DateWednesday, March 16, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 5, 2023
Registration Number5067812
Registration DateTuesday, October 25, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 9, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
Translation of Words in MarkThe wording "HIRAFBI" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 5, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, May 5, 2023CANCELLED SEC. 8 (6-YR)
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 25, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 25, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, August 9, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 9, 2016PUBLISHED FOR OPPOSITION
Wednesday, July 20, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 6, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, June 26, 2016ASSIGNED TO EXAMINER
Monday, March 21, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 19, 2016NEW APPLICATION ENTERED